<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    jbnb
   </journal-id>
   <journal-title-group>
    <journal-title>
     Journal of Biomaterials and Nanobiotechnology
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2158-7027
   </issn>
   <issn publication-format="print">
    2158-7043
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/jbnb.2025.162002
   </article-id>
   <article-id pub-id-type="publisher-id">
    jbnb-146311
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Biomedical 
     </subject>
     <subject>
       Life Sciences, Chemistry 
     </subject>
     <subject>
       Materials Science
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Green Synthesis and Characterization of Silver Nanoparticles Using Vachellia seyal Extract: A Comparative Physicochemical Study with Ascorbic Acid and Sodium Borohydride
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Abdou
      </surname>
      <given-names>
       Faye
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Sidy Mouhamed
      </surname>
      <given-names>
       Dieng
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Papa Mady
      </surname>
      <given-names>
       Sy
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Alphonse Rodrigue
      </surname>
      <given-names>
       Djiboune
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Fatoumata
      </surname>
      <given-names>
       Gaye
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Marie Jeanne Arlette
      </surname>
      <given-names>
       Cisse
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Mouhamed
      </surname>
      <given-names>
       Mbaye
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Kévin Berythane
      </surname>
      <given-names>
       Saha
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Louis Augustin Diaga
      </surname>
      <given-names>
       Diouf
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Gora
      </surname>
      <given-names>
       Mbaye
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Mounibé
      </surname>
      <given-names>
       Diarra
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aPhysical Pharmaceutics Laboratory, Faculty of Medicine, Pharmacy, and Odontology, Cheikh Anta Diop University, Dakar, Senegal
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aGalenic Pharmacy Laboratory, Faculty of Medicine, Pharmacy, and Odontology, Cheikh Anta Diop University, Dakar, Senegal
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     11
    </day> 
    <month>
     10
    </month>
    <year>
     2025
    </year>
   </pub-date> 
   <volume>
    16
   </volume> 
   <issue>
    02
   </issue>
   <fpage>
    21
   </fpage>
   <lpage>
    30
   </lpage>
   <history>
    <date date-type="received">
     <day>
      17,
     </day>
     <month>
      April
     </month>
     <year>
      2025
     </year>
    </date>
    <date date-type="published">
     <day>
      25,
     </day>
     <month>
      April
     </month>
     <year>
      2025
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      25,
     </day>
     <month>
      April
     </month>
     <year>
      2025
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    The green synthesis of silver nanoparticles (AgNPs) offers an eco-friendly and biocompatible alternative to conventional methods, which often involve toxic reagents. In this study, AgNPs were synthesized via chemical reduction using three different reducing agents: sodium borohydride (NaBH
    <sub>4</sub>), ascorbic acid, and a Vachellia seyal plant extract. UV-Visible spectroscopy confirmed the formation of AgNPs, with characteristic surface plasmon resonance bands observed at 430  nm for all three reducing agents. Dynamic Light Scattering (DLS) analysis revealed average particle sizes of 
    <b>18.69</b> 
    <b>±</b> 
    <b>0.04</b>  nm with a polydispersity index (PDI) of 
    <b>0.639</b> for NaBH
    <sub>4</sub>, 
    <b>42.44</b> 
    <b>±</b> 
    <b>5.37</b>
    <b> </b> nm with a PDI of 
    <b>0.234</b> 
    <b>±</b> 
    <b>0.074</b> for ascorbic acid, and 
    <b>129.53</b> 
    <b>±</b> 
    <b>0.57</b>  nm with a PDI of 
    <b>0.092</b> 
    <b>±</b> 
    <b>0.016</b> for V. seyal extract. Transmission Electron Microscopy (TEM) confirmed spherical morphology and sizes consistent with DLS measurements. These results indicate that the reducing strength of the agents significantly influences nanoparticle size and distribution. The V. seyal extract enabled the successful green synthesis of AgNPs with good size stability, highlighting its potential for pharmaceutical and biomedical applications.
   </abstract>
   <kwd-group> 
    <kwd>
     Silver Nanoparticles
    </kwd> 
    <kwd>
      Vachellia seyal
    </kwd> 
    <kwd>
      Green Synthesis
    </kwd> 
    <kwd>
      DLS
    </kwd> 
    <kwd>
      TEM
    </kwd> 
    <kwd>
      Polydispersity
    </kwd> 
    <kwd>
      Ascorbic Acid
    </kwd> 
    <kwd>
      NaBH
     <sub>4</sub>
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>The rise of nanoscience and nanotechnology has driven significant advances in the fabrication of nanoparticles, particularly silver nanoparticles (AgNPs), which have attracted increasing interest due to their remarkable physicochemical properties and wide-ranging applications in medicine, biotechnology, environmental science, and the pharmaceutical industry. Traditionally, their synthesis has relied on physicochemical processes involving toxic reagents, organic solvents, and energy-intensive production conditions, raising major concerns regarding environmental safety and biological compatibility.</p>
   <p>To overcome these limitations, green synthesis has emerged as an innovative, sustainable, and environmentally friendly alternative. This approach uses plant extracts, microorganisms (bacteria, fungi, microalgae), or natural biomolecules that act simultaneously as reducing and stabilizing agents. Green synthesis allows the production of clean, biocompatible, and stable nanoparticles, while offering improved control over size, shape, and distribution <xref ref-type="bibr" rid="scirp.146311-1">
     [1]
    </xref>-<xref ref-type="bibr" rid="scirp.146311-5">
     [5]
    </xref>. Moreover, the natural richness of plant extracts in bioactive compounds (phenols, flavonoids, enzymes, tannins, etc.) enhances the biological functionalization of nanoparticles, thereby opening new prospects in diagnostics, targeted therapy, tissue engineering, and antimicrobial coatings <xref ref-type="bibr" rid="scirp.146311-6">
     [6]
    </xref>-<xref ref-type="bibr" rid="scirp.146311-9">
     [9]
    </xref>.</p>
   <p>Several plant species have demonstrated strong potential for the biosynthesis of homogeneous AgNPs with sizes ranging from 10 to 50 nm, characterized by excellent colloidal stability and pronounced antibacterial and photocatalytic properties <xref ref-type="bibr" rid="scirp.146311-1">
     [1]
    </xref>. Numerous studies have also highlighted the crucial influence of synthesis parameters such as pH, temperature, and reaction time on the size, distribution, and functional properties of the resulting nanoparticles <xref ref-type="bibr" rid="scirp.146311-2">
     [2]
    </xref> <xref ref-type="bibr" rid="scirp.146311-3">
     [3]
    </xref>. For instance, AgNPs synthesized from Ficus carica have shown notable antibacterial, antibiofilm, and anticancer effects, with an IC₅₀ value of 8.4 µg/mL on certain cell lines <xref ref-type="bibr" rid="scirp.146311-4">
     [4]
    </xref> <xref ref-type="bibr" rid="scirp.146311-10">
     [10]
    </xref>.</p>
   <p>Similarly, Eugenia uniflora fruit extract has been reported to enable efficient green synthesis of silver nanoparticles with homogeneous morphology, good colloidal stability, and excellent antibacterial properties, highlighting the value of phytochemical-rich plant sources for the eco-responsible production of functional nanomaterials <xref ref-type="bibr" rid="scirp.146311-11">
     [11]
    </xref>. In another study, AgNPs biosynthesized from Sida acuta leaves were compared to nanocomposites combining these nanoparticles with reduced graphene oxide (rGO). The results revealed strong antibacterial activity, particularly against MRSA and Proteus mirabilis, as well as promising anticancer potential. These green nanoparticles, which were very small (−5 nm) and well dispersed, also exhibited notable antioxidant, anti-inflammatory, and anti-diabetic properties, underscoring their therapeutic potential <xref ref-type="bibr" rid="scirp.146311-12">
     [12]
    </xref>.</p>
   <p>In parallel, the use of microalgae such as Graesiella emersonii represents a promising strategy: extracellular metabolites produced by these microorganisms facilitate the reduction of metal ions and the stabilization of AgNPs in a bioinspired and finely regulated environment <xref ref-type="bibr" rid="scirp.146311-5">
     [5]
    </xref>. Recent developments have further enabled the incorporation of AgNPs into polymeric nanocomposites, opening new avenues for applications in regenerative medicine, drug delivery, and the design of smart antimicrobial materials <xref ref-type="bibr" rid="scirp.146311-6">
     [6]
    </xref>-<xref ref-type="bibr" rid="scirp.146311-9">
     [9]
    </xref>.</p>
   <p>In this context, the present study aims to investigate the potential of green synthesis of AgNPs from specific biological resources, to characterize the resulting nanoparticles, and to evaluate their colloidal stability. More specifically, the objective is to synthesize silver nanoparticles from Vachellia seyal extracts via a chemical reduction process using ascorbic acid, with sodium borohydride serving as a reference, and to characterize them using UV-Visible spectrophotometry, dynamic light scattering, and electron microscopy.</p>
  </sec><sec id="s2">
   <title>2. Materials and Methods</title>
   <sec id="s2_1">
    <title>2.1. Materials</title>
    <p>The reagents used in this study were silver nitrate (AgNO<sub>3</sub>), sodium borohydride (NaBH<sub>4</sub>) (Aldrich Laboratories), ascorbic acid (National Laboratory for Drug Quality Control), and Vachellia seyal extract prepared by the Pharmacognosy Laboratory of Cheikh Anta Diop University of Dakar. Additional reagents included sodium citrate, hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) (Gilbert Laboratories), and the solvents ethanol and methanol (Oxford Laboratories). The equipment employed consisted of a Heidolph MR 3001 K magnetic stirrer, a Mettler precision balance (model BC), and standard laboratory glassware and tools, including beakers, Erlenmeyer flasks, pipettes, micropipettes, spatulas, 10 mL test tubes, volumetric flasks, and filter paper.</p>
   </sec>
   <sec id="s2_2">
    <title>2.2. Methods</title>
    <p>The chemical reduction method is commonly employed to synthesize metallic nanoparticles with controlled size and shape. This approach involves the use of a metal precursor (such as silver nitrate, AgNO<sub>3</sub>), a reducing agent (such as sodium borohydride, NaBH<sub>4</sub>) to reduce metal ions, and a stabilizing agent to prevent nanoparticle agglomeration <xref ref-type="bibr" rid="scirp.146311-13">
      [13]
     </xref>-<xref ref-type="bibr" rid="scirp.146311-18">
      [18]
     </xref>. In this study, silver nanoparticles were synthesized by adding NaBH<sub>4</sub> to AgNO<sub>3</sub> to reduce +Ag<sup>+</sup> ions, in the presence of sodium citrate as a stabilizing agent. To induce the formation of silver nanoprisms, hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) was introduced to promote anisotropic growth, while potassium bromide (KBr) was used to control nanoparticle size. Thus, sodium citrate served as a stabilizer, H<sub>2</sub>O<sub>2</sub> directed anisotropic growth toward prism-like structures, and KBr regulated particle dimensions <xref ref-type="bibr" rid="scirp.146311-19">
      [19]
     </xref>.</p>
    <p>The synthesis was carried out in three steps. First, a control synthesis was performed using sodium borohydride as the reducing agent. In the second step, ascorbic acid was used as an alternative reducing agent. Finally, in the third step, synthesis was conducted using a plant extract as a green reducing agent. Each resulting solution was characterized by UV-Visible spectrophotometry, dynamic light scattering (DLS), and electron microscopy to assess their optical and structural properties.</p>
    <p>Despite the different synthesis conditions tested, only spherical nanoparticles were obtained and characterized.</p>
    <p>The previously described protocol was adapted by replacing sodium borohydride (NaBH<sub>4</sub>) with two biological reducing agents: a plant extract of Vachellia seyal and a solution of ascorbic acid. A 10<sup>−2</sup> mol·L<sup>−1</sup> (1.7612 g·L<sup>−1</sup>) ascorbic acid solution was prepared, and the samples were synthesized following the same procedure as for the NaBH<sub>4</sub>-based method. Similarly, a Vachellia seyal extract solution was prepared by dissolving 0.08806 g of the dried extract in 50 mL of distilled water in a 100 mL beaker containing a magnetic stir bar. After stirring for 10 minutes, the mixture was filtered into a 50 mL volumetric flask using filter paper. The corresponding samples were then prepared following the same steps as for NaBH<sub>4</sub>. For all samples, UV-Visible absorption spectra were recorded to monitor nanoparticle formation and characterize their properties.</p>
    <p>Absorption spectrophotometry: UV-Visible spectroscopy is a widely used and reliable analytical technique for the primary characterization of synthesized nanoparticles. It is particularly useful for monitoring nanoparticle formation and assessing the stability of silver nanoparticles <xref ref-type="bibr" rid="scirp.146311-20">
      [20]
     </xref> <xref ref-type="bibr" rid="scirp.146311-21">
      [21]
     </xref>. This method relies on the absorption of a monochromatic beam of light in the ultraviolet (UV) or visible range as it passes through a medium containing an absorbing species. The amount of light absorbed is proportional to the concentration of that species, according to Beer-Lambert’s law. For nanoparticles, the absorption maxima are associated with surface plasmon resonance and can be used to estimate the average size of nanoprism particles. These values can then be compared to a calibration curve to determine particle dimensions. The UV-Visible absorption spectra of the synthesized samples were recorded using a Thermo Scientific® Evolution 3000 UV-Visible spectrophotometer, operated with Vision Pro software, ensuring accurate and reproducible measurements.</p>
    <p>Size and charge measurement: The size distribution and polydispersity index (PDI) of the nanoparticles were measured using a Nanosizer (Malvern Instruments, Orsay, France) through dynamic light scattering (DLS) techniques. All experiments were performed in triplicate to ensure accuracy and reproducibility.</p>
    <p>Morphological characterization: The morphology of the nanoparticles was examined using a Philips Morgagni 268 D Transmission Electron Microscope (TEM) operating at 70 kV. No staining agents were used, and the samples were diluted 100-fold with MilliQ water. A drop of the diluted sample was placed onto a carbon-coated copper grid (Type A, 300 mesh, Redding, PA) and dried at 40˚C prior to imaging.</p>
   </sec>
  </sec><sec id="s3">
   <title>3. Results</title>
   <p>The synthesis was carried out by chemical reduction in three steps. First, a control synthesis was performed using sodium borohydride (NaBH<sub>4</sub>). Next, a second synthesis was conducted using ascorbic acid as the reducing agent. Finally, the last synthesis was carried out with the Vachellia seyal extract. Each resulting solution was characterized by UV-Visible spectrophotometry, dynamic light scattering, and electron microscopy (performed for the synthesis using the V. seyal extract) to analyze their optical and structural properties.</p>
   <p>Upon addition of the NaBH<sub>4</sub> solution at 5.0 × 10<sup>−3</sup> mol·L<sup>−1</sup>, the reaction mixture immediately changed color: yellow after one minute, followed by orange, then brown, gray, and finally blue after approximately three minutes. The corresponding absorption spectrum is shown in <xref ref-type="fig" rid="fig1">
     Figure 1
    </xref>.</p>
   <fig id="fig1" position="float">
    <label>Figure 1</label>
    <caption>
     <title>
      <xref ref-type="bibr" rid="scirp.146311-"></xref>Figure 1. The ultraviolet-visible spectra of synthesized silver nanoparticles using NaBH<sub>4</sub>.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/3200693-rId17.jpeg?20251022043625" />
   </fig>
   <fig id="fig2" position="float">
    <label>Figure 2</label>
    <caption>
     <title>
      <xref ref-type="bibr" rid="scirp.146311-"></xref>Figure 2. The ultraviolet-visible spectra of synthesized silver nanoparticles using Ascorbic acid.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/3200693-rId18.jpeg?20251022043625" />
   </fig>
   <p>After the addition of the ascorbic acid solution at 1.0 × 10<sup>−2</sup> mol·L<sup>−1</sup>, the reaction mixture changed color, turning light blue after approximately three minutes. The corresponding absorption spectrum is shown in <xref ref-type="fig" rid="fig2">
     Figure 2
    </xref>.</p>
   <p>After the addition of the Vachellia seyal extract solution at 1.7612 g·L<sup>−1</sup>, the reaction mixture rapidly developed an orange color, which remained stable after several minutes of stirring. The corresponding absorption spectrum is shown in <xref ref-type="fig" rid="fig3">
     Figure 3
    </xref>.</p>
   <fig id="fig3" position="float">
    <label>Figure 3</label>
    <caption>
     <title>
      <xref ref-type="bibr" rid="scirp.146311-"></xref>Figure 3. The ultraviolet-visible spectra of biosynthesized silver nanoparticles using V. seyal.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/3200693-rId19.jpeg?20251022043625" />
   </fig>
   <sec id="s3_1">
    <title>3.1. Size and Charges Measurements</title>
    <p>Characterization of the preparations by DLS revealed the presence of nanoparticles in all samples, with size distributions varying depending on whether the synthesis was performed using NaBH<sub>4</sub>, ascorbic acid, or the V. seyal extract (<xref ref-type="fig" rid="fig4">
      Figure 4
     </xref>).</p>
    <fig id="fig4" position="float">
     <label>Figure 4</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.146311-"></xref>Figure 4. Size distribution of AgNPs obteined with different reductor (Black, NaBH<sub>4</sub>; Red, Ascorbic; Blue, V. seyal).</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/3200693-rId20.jpeg?20251022043625" />
    </fig>
    <table-wrap id="table1">
     <label>
      <xref ref-type="table" rid="table1">
       Table 1
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.146311-"></xref>Table 1. Size distribution and polydispersity according to the reducing agent.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="31.50%"><p style="text-align:center">Reducing agent</p></td> 
       <td class="custom-bottom-td acenter" width="31.52%"><p style="text-align:center">Size (nm)</p></td> 
       <td class="custom-bottom-td acenter" width="31.52%"><p style="text-align:center">PDI</p></td> 
      </tr> 
      <tr> 
       <td rowspan="3" class="custom-top-td acenter" width="31.50%"><p style="text-align:center">NaBH<sub>4</sub></p></td> 
       <td class="custom-top-td acenter" width="31.52%"><p style="text-align:center">18.64</p></td> 
       <td class="custom-top-td acenter" width="31.52%"><p style="text-align:center">0.640</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="31.52%"><p style="text-align:center">18.75</p></td> 
       <td class="acenter" width="31.52%"><p style="text-align:center">0.638</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="31.52%"><p style="text-align:center">18.68</p></td> 
       <td class="custom-bottom-td acenter" width="31.52%"><p style="text-align:center">0.639</p></td> 
      </tr> 
      <tr> 
       <td rowspan="3" class="custom-top-td acenter" width="31.50%"><p style="text-align:center">Ascorbic acide</p></td> 
       <td class="custom-top-td acenter" width="31.52%"><p style="text-align:center">50.51</p></td> 
       <td class="custom-top-td acenter" width="31.52%"><p style="text-align:center">0.132</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="31.52%"><p style="text-align:center">40.36</p></td> 
       <td class="acenter" width="31.52%"><p style="text-align:center">0.225</p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="31.52%"><p style="text-align:center">36.47</p></td> 
       <td class="custom-bottom-td acenter" width="31.52%"><p style="text-align:center">0.345</p></td> 
      </tr> 
      <tr> 
       <td rowspan="3" class="custom-top-td acenter" width="31.50%"><p style="text-align:center"><u>Vachellia</u> <u>seyal</u></p></td> 
       <td class="custom-top-td acenter" width="31.52%"><p style="text-align:center">130.4</p></td> 
       <td class="custom-top-td acenter" width="31.52%"><p style="text-align:center">0.118</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="31.52%"><p style="text-align:center">128.7</p></td> 
       <td class="acenter" width="31.52%"><p style="text-align:center">0.077</p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="31.52%"><p style="text-align:center">129.5</p></td> 
       <td class="acenter" width="31.52%"><p style="text-align:center">0.083</p></td> 
      </tr> 
     </table>
    </table-wrap>
   </sec>
   <sec id="s3_2">
    <title>3.2. Morphological Characterization</title>
    <p>Morphological characterization of the nanoparticles (AgNPs) was conducted using Transmission Electron Microscopy (TEM) (see <xref ref-type="fig" rid="fig5">
      Figure 5
     </xref>). The AgNPs (<xref ref-type="fig" rid="figFigures 5(a)-(c)">
      Figures 5(a)-(c)
     </xref>) appeared as round spheres, with a size consistent with the dynamic light scattering (DLS) results, showing a distribution centered around a diameter of 130 nm. Some nanoparticles were isolated on the carbon support, while others formed aggregates (see <xref ref-type="table" rid="table1">
      Table 1
     </xref>) or clusters, a typical occurrence during sample drying.</p>
    <fig id="fig5" position="float">
     <label>Figure 5</label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.146311-"></xref>Figure 5. Transmission electron micrograph of AgNPs using the V. seyal extract (a) scale bar 500 nm (b) scale bar 200 nm (c) scale bar 100 nm.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/3200693-rId21.jpeg?20251022043626" />
    </fig>
   </sec>
  </sec><sec id="s4">
   <title>4. Discussion</title>
   <p>The absorption spectrum of the NaBH<sub>4</sub>-synthesized sample exhibits a broad band between 350 and 500 nm, confirming the presence of nanoparticles with a highly polydisperse size distribution <xref ref-type="bibr" rid="scirp.146311-22">
     [22]
    </xref>. In contrast, the sample synthesized with ascorbic acid shows a much narrower band with an absorption maximum at 430 nm, indicating a lower degree of polydispersity and nanoparticles ranging in size from 60 to 70 nm. For the sample synthesized with ascorbic acid, which is a weaker reducing agent than NaBH<sub>4</sub>, the spectrum displays a very broad band, suggesting a very high polydispersity index, with an absorption maximum at 430 nm.</p>
   <p>For the Vachellia seyal extract, the absorption spectra of the resulting nanoparticles display moderately narrow bands, suggesting a relatively low to moderate polydispersity. Silver nanoparticles exhibit unique optical properties that enable strong interactions with specific wavelengths of light. Numerous studies have shown that, in general, absorption bands in the 200 - 800 nm range are optimal for characterizing nanoparticles with sizes between 2 and 100 m. In silver nanoparticles, the conduction and valence bands are very close, allowing electrons to move freely. These free electrons give rise to a surface plasmon resonance (SPR) absorption band, resulting from the collective oscillation of electrons in resonance with incident light. The SPR band depends on particle size, the dielectric medium, and the chemical environment. The presence of a surface plasmon peak is well documented for metallic nanoparticles in the 2 - 100 nm range <xref ref-type="bibr" rid="scirp.146311-20">
     [20]
    </xref> <xref ref-type="bibr" rid="scirp.146311-21">
     [21]
    </xref> <xref ref-type="bibr" rid="scirp.146311-23">
     [23]
    </xref>.</p>
   <p>Characterization by DLS confirmed the presence of silver nanoparticles. NaBH<sub>4</sub>-synthesized nanoparticles had an average size of 18.69 ± 0.04 nm with a polydispersity index (PDI) of 0.639. Using ascorbic acid, the average nanoparticle size was 42.44 ± 5.37 nm with a PDI of 0.234 ± 0.074. The use of V. seyal extract significantly increased particle size to 129.53 ± 0.57 nm, with a PDI of 0.092 ± 0.016. These results indicate an inverse relationship between nanoparticle size and polydispersity index and confirm that nanoparticle size correlates with the reducing strength of the agent <xref ref-type="bibr" rid="scirp.146311-23">
     [23]
    </xref>-<xref ref-type="bibr" rid="scirp.146311-25">
     [25]
    </xref>.</p>
   <p>Overall, these findings demonstrate the feasibility of green synthesis using plant extracts to produce silver nanoparticles with controlled sizes suitable for pharmaceutical applications. Morphological characterization by electron microscopy further confirmed the successful biosynthesis of these nanoparticles.</p>
  </sec><sec id="s5">
   <title>5. Conclusion</title>
   <p>This study demonstrates the successful synthesis of silver nanoparticles (AgNPs) using both conventional (NaBH<sub>4</sub>, ascorbic acid) and green (Vachellia seyal extract) reducing agents. Spectroscopic and microscopic analyses confirmed the formation of AgNPs in all cases, with notable differences in size and polydispersity depending on the reducing agent used. In particular, nanoparticles synthesized with V. seyal extract exhibited larger sizes but a lower polydispersity index, indicating good colloidal stability and uniformity. These results highlight the critical role of the reducing agent’s antioxidant capacity in determining nanoparticle characteristics. The green synthesis approach using V. seyal not only provides an environmentally sustainable alternative but also offers promising potential for biomedical and pharmaceutical applications, owing to its simplicity, eco-compatibility, and the biofunctional properties of the plant-derived compounds. Future studies will focus on optimizing synthesis parameters and evaluating the biological activities of these nanoparticles for potential therapeutic applications.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.146311-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Shahzadi, A. (2025) Plant-Mediated Green Synthesis and Biomedical Applications of Silver Nanoparticles: A Comparative Study Using Ocimum sanctum, Curcuma longa and Azadirachta indica Extracts. 
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Haridas, E.S., Bhattacharya, S., Varma, M.K. and Chandra, G.K. (2022) Green Synthesis of Eco-Friendly Silver Nanoparticles Using Coffea arabica Leaf Extract and Development of a Biosensor for Cysteine. &gt;https://doi.org/10.48550/arXiv.2209.03823
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Do, J.-M., Hong, J.W. and Yoon, H.-S. (2025) Microalgae-Mediated Green Synthesis of Silver Nanoparticles: A Sustainable Approach Using Extracellular Polymeric Substances from Graesiella emersonii. Frontiers in Microbiology, 16, Article 1589285. &gt;https://doi.org/10.3389/fmicb.2025.1589285
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Khan, A.U., Hussain, T., Abdullah Khan, M.A., Almostafa, M.M., Younis, N.S. and Yahya, G. (2023) Antibacterial and Antibiofilm Activity of Ficus carica-Mediated Calcium Oxide (CaONPs) Phyto-Nanoparticles. Molecules, 28, Article 5553. &gt;http://doi.org/10.3390/molecules28145553
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Rajak, K.K., Pahilani, P.P., Patel, H., et al. (2023) Green Synthesis of Silver Nanoparticles Using Curcuma longa Flower Extract and Antibacterial Activity. &gt;https://doi.org/10.48550/arXiv.2304.04777
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Dilbar, S., Sher, H., Ali, A., et al. (2023) Antibacterial Efficacy of Green Synthesized Silver Nanoparticles Using Salvia nubicola Extract. ACS Omega, 8, 31155-31167. &gt;https://doi.org/10.1021/acsomega.3c03164
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Rizwana, H., Alzahrani, T., Alwahibi, M.S., et al. (2025) Phytofabrication of AgNPs Using Psidium guajava Leaf Extract: Antifungal Activity against Phytopathogens. BMC Plant Biology, 25, Article No. 65. 
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Asefian, S. and Ghavam, M. (2024) Green and Environmentally Friendly Synthesis of Silver Nanoparticles with Antibacterial Properties from Some Medicinal Plants. BMC Biotechnology, 24, Article No. 5. &gt;https://doi.org/10.1186/s12896-023-00828-z 
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Arshad, F., Naikoo, G.A., Hassan, I.U., Chava, S.R., El-Tanani, M., Aljabali, A.A., et al. (2024) Bioinspired and Green Synthesis of Silver Nanoparticles for Medical Applications: A Green Perspective. Applied Biochemistry and Biotechnology, 196, 3636-3669. &gt;https://doi.org/10.1007/s12010-023-04719-z 
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Rehman, G., Umar, M., Shah, N., Hamayun, M., Ali, A., Khan, W., et al. (2023) Green Synthesis and Characterization of Silver Nanoparticles Using Azadirachta indica Seeds Extract: In Vitro and in Vivo Evaluation of Anti-Diabetic Activity. Pharmaceuticals, 16, Article 1677. &gt;https://doi.org/10.3390/ph16121677
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Moya, M., Bagnarello, V., Mora, J. and Valerio, I. (2023) Green Synthesis and Antibacterial Properties of Silver Nanoparticles from Eugenia uniflora Fruit Extract. Advances in Nanoparticles, 12, 94-105. &gt;https://doi.org/10.4236/anp.2023.123008
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Balaji, V., Perumal, S., Palanisamy, S., Karuppaiah, M., Asaithambi, S., Velauthapillai, D., et al. (2023) Bio-Inspired Synthesis of Silver Nanoparticles and Their Nanocomposites for Antibacterial and Anticancer Activity: A Comparative Study. Journal of Alloys and Compounds, 966, Article 171503. &gt;https://doi.org/10.1016/j.jallcom.2023.171503
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Xu, L., Wang, Y., Huang, J., Chen, C., Wang, Z. and Xie, H. (2020) Silver Nanoparticles: Synthesis, Medical Applications and Biosafety. Theranostics, 10, 8996-9031. &gt;https://doi.org/10.7150/thno.45413
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Panáček, A., Kvítek, L., Prucek, R., Kolář, M., Večeřová, R., Pizúrová, N., et al. (2006) Silver Colloid Nanoparticles: Synthesis, Characterization, and Their Antibacterial Activity. The Journal of Physical Chemistry B, 110, 16248-16253. &gt;https://doi.org/10.1021/jp063826h
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Sahoo, P., Kamal, S., Kumar, T., Sreedhar, B., Singh, A. and Srivastava, S. (2009) Synthesis of Silver Nanoparticles Using Facile Wet Chemical Route. Defence Science Journal, 59, 447-455. &gt;https://doi.org/10.14429/dsj.59.1545
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lanje, A.S., Sharma, S.J. and Pode, R.B. (2010) Synthesis of Silver Nanoparticles: A Safer Alternative to Conventional Antimicrobial and Antibacterial Agents. Journal of Chemical and Pharmaceutical Research, 2, 478-483.
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Aguilar-Méndez, M.A., San Martín-Martínez, E., Ortega-Arroyo, L., Cobián-Portillo, G. and Sánchez-Espíndola, E. (2011) Synthesis and Characterization of Silver Nanoparticles: Effect on Phytopathogen Colletotrichum Gloesporioides. Journal of Nanoparticle Research, 13, 2525-2532. &gt;https://doi.org/10.1007/s11051-010-0145-6 
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Meshram, S.M., Bonde, S.R., Gupta, I.R., Gade, A.K. and Rai, M.K. (2013) Green Synthesis of Silver Nanoparticles Using White Sugar. IET Nanobiotechnology, 7, 28-32. &gt;https://doi.org/10.1049/iet-nbt.2012.0002 
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Roto, R., Rasydta, H.P., Suratman, A. and Aprilita, N.H. (2018) Effect of Reducing Agents on Physical and Chemical Properties of Silver Nanoparticles. Indonesian Journal of Chemistry, 18, 614-620. &gt;https://doi.org/10.22146/ijc.26907
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zhang, X., Liu, Z., Shen, W. and Gurunathan, S. (2016) Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches. International Journal of Molecular Sciences, 17, Article 1534. &gt;https://doi.org/10.3390/ijms17091534
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Almatroudi, A. (2020) Silver Nanoparticles: Synthesis, Characterisation and Biomedical Applications. Open Life Sciences, 15, 819-839. &gt;https://doi.org/10.1515/biol-2020-0094
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Paramelle, D., Sadovoy, A., Gorelik, S.P., Hobley, J. and Fernig, D.G. (2014) A Rapid Method to Estimate the Concentration of Citrate Capped Silver Nanoparticles from UV-Visible Light Spectra. The Analyst, 139, Article 4855. &gt;https://doi.org/10.1039/c4an00978a
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref23">
    <label>23</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Stetefeld, J., McKenna, S.A. and Patel, T.R. (2016) Dynamic Light Scattering: A Practical Guide and Applications in Biomedical Sciences. Biophysical Reviews, 8, 409-427. &gt;https://doi.org/10.1007/s12551-016-0218-6 
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref24">
    <label>24</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Nobbmann, U., Connah, M., Fish, B., Varley, P., Gee, C., Mulot, S., et al. (2007) Dynamic Light Scattering as a Relative Tool for Assessing the Molecular Integrity and Stability of Monoclonal Antibodies. Biotechnology and Genetic Engineering Reviews, 24, 117-128. &gt;https://doi.org/10.1080/02648725.2007.10648095 
    </mixed-citation>
   </ref>
   <ref id="scirp.146311-ref25">
    <label>25</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bhattacharjee, S. (2016) DLS and Zeta Potential—What They Are and What They Are Not? Journal of Controlled Release, 235, 337-351. &gt;https://doi.org/10.1016/j.jconrel.2016.06.017
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>